Search Results - "Schaefer, Jacob J."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP by Chen, Yang, Schaefer, Jacob J, Iyer, Seethalakshmi R, Harders, Gerald E, Pan, Shuchong, Sangaralingham, S Jeson, Chen, Horng H, Redfield, Margaret M, Burnett, Jr, John C

    “…Based on the cardiac hormone atrial natriuretic peptide (ANP) and its seminal role in blood pressure (BP) homeostasis, we investigated the chronic BP lowering…”
    Get more information
    Journal Article
  2. 2

    The effect of diuresis on extravascular lung water and pulmonary function in acute decompensated heart failure by Chase, Steven C., Fermoyle, Caitlin C., Wheatley, Courtney M., Schaefer, Jacob J., Olson, Lyle J., Johnson, Bruce D.

    Published in ESC Heart Failure (01-04-2018)
    “…Aims The effect of extravascular lung water (EVLW) and relationship to functional status as a result of acute decompensated heart failure (ADHF) are not well…”
    Get full text
    Journal Article
  3. 3

    Left ventricle assist device pulsatility index at the time of implantation is associated with follow-up pulmonary hemodynamics by Schaefer, Jacob J, Sajgalik, Pavol, Kushwaha, Sudhir S, Olson, Lyle J, Stulak, John M, Johnson, Bruce D, Schirger, John A

    Published in International journal of artificial organs (01-07-2020)
    “…HeartMate II left ventricular assist device controllers provide data including pulsatility index, reflecting the relationship between pump function and…”
    Get full text
    Journal Article
  4. 4

    Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure by Ma, Xiao, Chen, Yang, Reginauld, Shawn H., Scott, Christopher G., Iyer, Seethalakshmi R., Schaefer, Jacob J., Ichiki, Tomoko, Chen, Horng H., Rule, Andrew D., Burnett, John C., Sangaralingham, S. Jeson

    Published in JACC. Heart failure (01-09-2021)
    “…This study sought to characterize urinary and plasma C-type natriuretic peptide (CNP) in acute decompensated heart failure (ADHF) to define their relationship…”
    Get full text
    Journal Article
  5. 5

    Implementation of formal prescription guidelines reduces the economic cost of unused opioids after orthopedic surgery by Schaefer, Jacob J, Nouraee, Cyrus M, Blake, Nathan T, McGaver, Rebecca Stone, Uzlik, Rachel M, Wyard, Gary E, Giveans, M Russell

    “…Prior literature has reported on the concerning emergence of opioid overprescribing, yet there remains a lack of knowledge in understanding the cost of waste…”
    Get full text
    Journal Article
  6. 6

    Opioid-Prescribing Practices Between Total Knee and Hip Arthroplasty in an Outpatient Versus Inpatient Setting by Nouraee, Cyrus M., McGaver, Rebecca Stone, Schaefer, Jacob J., O'Neill, Owen R., Anseth, Scott D., Lehman-Lane, Justina, Uzlik, Rachel M., Giveans, M. Russell

    Published in Journal for healthcare quality (01-03-2022)
    “…Despite trends showing increases in the utilization of outpatient (OP) ambulatory surgery centers (ASCs) and decreases in the utilization of inpatient (IP)…”
    Get full text
    Journal Article
  7. 7

    Prognostic Implications of Urinary and Plasma C-type Natriuretic Peptide in Human Acute Decompensated Heart Failure by Ma, Xiao, Chen, Yang, Reginauld, Shawn H., Scott, Christopher G., Iyer, Seethalakshmi R., Schaefer, Jacob J., Ichiki, Tomoko, Chen, Horng H., Rule, Andrew D., Burnett, John C., Sangaralingham, S. Jeson

    Published in Journal of cardiac failure (01-10-2020)
    “…C-type natriuretic peptide (CNP) is a cardiorenal-derived hormone that possesses potent anti-fibrotic, anti-hypertrophic, anti-apoptotic and cardiac unloading…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Abstract 12837: Type I and Type II Heart Failure Defined: Novel Phenotypes Utilizing the Natriuretic Peptides and Cyclic Guanosine Monophosphate by Schaefer, Jacob J, Iyer, Seethalakshmi R, Chen, Yang, Sangaralingham, Jeson, Burnett, John C

    Published in Circulation (New York, N.Y.) (19-11-2019)
    “…IntroductionThe natriuretic peptide (NP)/particulate guanylyl cyclase (pGC)/3’5’ cyclic guanosine monophosphate (cGMP) system is critical for cardiorenal…”
    Get full text
    Journal Article
  10. 10

    Abstract 12347: C53: An Innovative GC-B Activating Drug Targeting Cardiorenal Fibrosis and the Progression to CKD-induced Heart Failure by Chen, Yang, Iyer, Seethalakshmi R, Harders, Gerald E, Schaefer, Jacob J, Ichiki, Tomoko, Burnett, John C, Sangaralingham, Jeson

    Published in Circulation (New York, N.Y.) (19-11-2019)
    “…IntroductionThe development of fibrosis in both the kidney and heart is a major driver for the progression to heart failure (HF) in chronic kidney disease…”
    Get full text
    Journal Article
  11. 11

    Implementation of Strategies to Reduce Improper Disposal of Opioids Following Orthopedic Surgery: A Pilot Study by Schaefer, Primary Investigators: Jacob J., Nouraee, Cyrus M., Oja, Karen J., Diekmann, Co-Investigators: Paul R., McGaver, Rebecca Stone, Giveans, M. Russell

    Published in Journal of perianesthesia nursing (01-08-2021)
    “…The opioid epidemic remains a challenging problem currently facing healthcare systems. As opioids are often prescribed in greater quantities than patients…”
    Get full text
    Journal Article